Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$41.99 - $62.38 $71,676 - $106,482
1,707 Added 2.73%
64,303 $3.78 Million
Q3 2023

Nov 08, 2023

BUY
$27.8 - $45.35 $2,502 - $4,081
90 Added 0.14%
62,596 $2.73 Million
Q2 2023

Aug 11, 2023

SELL
$36.13 - $49.49 $49,353 - $67,603
-1,366 Reduced 2.14%
62,506 $2.26 Million
Q4 2022

Feb 07, 2023

SELL
$41.27 - $98.62 $60,666 - $144,971
-1,470 Reduced 2.25%
63,872 $2.89 Million
Q3 2022

Nov 08, 2022

SELL
$59.5 - $86.7 $83,300 - $121,380
-1,400 Reduced 2.1%
65,342 $4.56 Million
Q2 2022

Aug 05, 2022

BUY
$39.16 - $88.71 $824,592 - $1.87 Million
21,057 Added 46.09%
66,742 $4.48 Million
Q1 2022

May 06, 2022

SELL
$75.82 - $150.97 $71,877 - $143,119
-948 Reduced 2.03%
45,685 $3.76 Million
Q4 2021

Feb 08, 2022

BUY
$132.01 - $190.29 $1.68 Million - $2.42 Million
12,733 Added 37.56%
46,633 $6.84 Million
Q3 2021

Nov 08, 2021

BUY
$132.13 - $177.45 $924,513 - $1.24 Million
6,997 Added 26.01%
33,900 $6 Million
Q2 2021

Aug 10, 2021

BUY
$144.0 - $179.73 $1.51 Million - $1.89 Million
10,496 Added 63.97%
26,903 $4.35 Million
Q1 2021

May 10, 2021

BUY
$158.92 - $221.61 $1,589 - $2,216
10 Added 0.06%
16,407 $2.81 Million
Q4 2020

Feb 08, 2021

BUY
$162.05 - $240.27 $95,609 - $141,759
590 Added 3.73%
16,397 $3.6 Million
Q3 2020

Nov 09, 2020

BUY
$113.26 - $167.27 $188,011 - $277,668
1,660 Added 11.73%
15,807 $2.63 Million
Q2 2020

Aug 07, 2020

BUY
$72.01 - $120.39 $56,527 - $94,506
785 Added 5.87%
14,147 $1.62 Million
Q2 2019

Aug 05, 2019

BUY
$59.49 - $104.71 $188,583 - $331,930
3,170 Added 31.1%
13,362 $1.38 Million
Q1 2019

May 03, 2019

BUY
$43.65 - $78.95 $12,658 - $22,895
290 Added 2.93%
10,192 $747,000
Q4 2018

Feb 01, 2019

BUY
$32.0 - $47.43 $95,424 - $141,436
2,982 Added 43.09%
9,902 $420,000
Q3 2018

Oct 31, 2018

BUY
$47.1 - $62.7 $62,643 - $83,391
1,330 Added 23.79%
6,920 $326,000
Q2 2018

Aug 06, 2018

BUY
$26.05 - $52.4 $145,619 - $292,916
5,590 New
5,590 $276,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.